Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy at Risk for Developing Infections and/or Cytokine Release Syndrome
Brief Summary:
IDION is currently seeking FDA approval for this device- the IDION iTempShield.
It is a skin-safe, FDA complaint and non-invasive device that can read and monitor skin temperature.
Having continuous temperature monitoring using the IDION iTempShield may provide early detection of a fever for patients with febrile neutropenia.
Febrile neutropenic fever is common in patients receiving chemotherapy and can often indicate infection.
The main potential benefit potenially experienced from participating in this study would be the early detection of fever.
There is a potential benefit that infection will be detected earlier in subjects wearing the IDION iTempShield.